癌症治疗支出 - 2026年8月底

截至2026年8月底，癌症治疗在PPI-肿瘤治疗量方面继续强劲攀升。

这以不变美元表示 - 所有价格上涨和通货膨胀均已剔除。癌症带来的额外消费者负担达530亿美元。

我们继续证实年复合增长率为3.5%，涨幅达28%，这与新冠疫苗mRNA疫苗的推出相吻合。

CDC SEER年龄调整发病率截至2023年证实了这一点（第2 y轴橙色）

TES是对的……2021年7月发现了这个信号。

Cancer Treatment Expenditures - EOM Aug 2026

As of end of month August 2026 cancer treatment continues its robust escalation in PPI-Neoplasm Treatment volume.

This is expressed in Constant Dollars - all price escalations and inflation are removed. $53 billion in added consumer burden from cancer.

We continue to substantiate a 3.5% CAGR and an elevation of 28%, which arrived commensurate with the rollout of the Covid-19 mRNA vaccine.

CDC SEER Age-Adjusted Incidence Rates through 2023 corroborate this (2nd y-axis orange)

TES was right... found this signal in July 2021.